Next Article in Journal
The Effect of Secretory Factors of Adipose-Derived Stem Cells on Human Keratinocytes
Previous Article in Journal
Targeting Protective Autophagy Exacerbates UV-Triggered Apoptotic Cell Death
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2012, 13(1), 1225-1238; doi:10.3390/ijms13011225

Disruption of Axonal Transport in Motor Neuron Diseases

1
Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
2
Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), Saitama 332-0012, Japan
*
Authors to whom correspondence should be addressed.
Received: 2 November 2011 / Revised: 11 January 2012 / Accepted: 16 January 2012 / Published: 23 January 2012
View Full-Text   |   Download PDF [310 KB, uploaded 19 June 2014]   |  

Abstract

Motor neurons typically have very long axons, and fine-tuning axonal transport is crucial for their survival. The obstruction of axonal transport is gaining attention as a cause of neuronal dysfunction in a variety of neurodegenerative motor neuron diseases. Depletions in dynein and dynactin-1, motor molecules regulating axonal trafficking, disrupt axonal transport in flies, and mutations in their genes cause motor neuron degeneration in humans and rodents. Axonal transport defects are among the early molecular events leading to neurodegeneration in mouse models of amyotrophic lateral sclerosis (ALS). Gene expression profiles indicate that dynactin-1 mRNA is downregulated in degenerating spinal motor neurons of autopsied patients with sporadic ALS. Dynactin-1 mRNA is also reduced in the affected neurons of a mouse model of spinal and bulbar muscular atrophy, a motor neuron disease caused by triplet CAG repeat expansion in the gene encoding the androgen receptor. Pathogenic androgen receptor proteins also inhibit kinesin-1 microtubule-binding activity and disrupt anterograde axonal transport by activating c-Jun N-terminal kinase. Disruption of axonal transport also underlies the pathogenesis of spinal muscular atrophy and hereditary spastic paraplegias. These observations suggest that the impairment of axonal transport is a key event in the pathological processes of motor neuron degeneration and an important target of therapy development for motor neuron diseases. View Full-Text
Keywords: axonal transport; dynactin-1; dynein; kinesin; neurofilament; motor neuron; amyotrophic lateral sclerosis; spinal and bulbar muscular atrophy; spinal muscular atrophy; hereditary spastic paraplegia axonal transport; dynactin-1; dynein; kinesin; neurofilament; motor neuron; amyotrophic lateral sclerosis; spinal and bulbar muscular atrophy; spinal muscular atrophy; hereditary spastic paraplegia
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ikenaka, K.; Katsuno, M.; Kawai, K.; Ishigaki, S.; Tanaka, F.; Sobue, G. Disruption of Axonal Transport in Motor Neuron Diseases. Int. J. Mol. Sci. 2012, 13, 1225-1238.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top